• Title of article

    Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease

  • Author/Authors

    Enayati، Samaneh نويسنده Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran , , Seifirad، Soroush نويسنده Research Fellow, Department of Cardiology, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran , , Amiri، Parvin نويسنده Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran , , Abolhalaj، Milad نويسنده Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran , , Mohammad -Amoli، Mahsa نويسنده Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran ,

  • Issue Information
    دوماهنامه با شماره پیاپی 49 سال 2015
  • Pages
    8
  • From page
    267
  • To page
    274
  • Abstract
    BACKGROUND: Several inflammatory mediators have been proposed to contribute to the pathogenesis of atherosclerosis. The aim of this study was to evaluate the quantitative expression of pro-inflammatory cytokines in un-stimulated peripheral blood mononuclear cell of patients with coronary artery disease (CAD). METHODS: Interleukin-1 beta (IL-1B), tumor necrosis factor-alpha, and interferon-gamma (IFN-?) gene expression were evaluated in angiography confirmed patients with and without CAD in a case-control study using quantitative real-time polymerase chain reaction. RESULTS: A significant increase (P = 0.030) in IL-1B gene expression was found in patients with CAD [median interquartile range (IQR) = 4.890 (6.084)] compared to patients without CAD [median (IQR) = 1.792 (3.172)]. Despite the increase in IFN-? gene expression in patients with CAD [median (IQR) = 1.298 (3.896)] versus patients without CAD [median (IQR) = 0.841 (2.79)], there was not statistically significant difference (P = 0.990). CONCLUSION: Our results provide evidence for possible association between IL-1B and development of atherosclerosis as a crucial cytokine that induce a network of signaling pathways. This finding if proved in future would suggest IL-1B as a potent therapeutic target in CAD.
  • Journal title
    Arya Atherosclerosis
  • Serial Year
    2015
  • Journal title
    Arya Atherosclerosis
  • Record number

    2336826